FDA panel to examine Moderna's mRNA flu vaccine
Presented by Philip Morris International {beacon} View Online Health Care Health Care PRESENTED BY The Big Story FDA panel set to review Moderna mRNA flu shot FDA’s vaccine advisors seem open to Moderna’s candidate for a mRNA flu vaccine ahead of a key meeting on Thursday. The company is seeking traditional approval for people...
The FDA's vaccine advisory committee is preparing to evaluate Moderna's mRNA-based flu vaccine. This review is a significant step in the potential approval process. The panel will assess the vaccine's safety and effectiveness. Moderna is aiming for traditional approval for the vaccine. The meeting is scheduled for Thursday and could influence future public health strategies. The outcome may impact how flu vaccines are developed and distributed. This decision could affect the availability of new vaccination options.
The decision could shape the future of flu vaccine development and public health approaches.
📌 Kaynak
Bu haber XML kaynağından derlenmiştir. Tamamı için orijinal habere gidin.
Orijinal haberi oku →